The laboratory LabTAU for Laboratory of Therapeutic Applications of Ultrasound (Claude Bernard Lyon 1 University and INSERM Unit 1032), under the direction of Jean-Yves Chapelon, is specialized in the development of new non-invasive or minimally invasive therapeutic applications of image-guided ultrasound, by combining experimental and theoretical research for which very few teams, even international, possess the required know-how.
Since January 1, 2005, the laboratory has produced 198 publications in refereed journals and 190 communications, including 22 invited communications. Technological or methodological expertise of the team and its partners covers the entire range of investigations from the bench to the bedside.
Several successful technology transfers took place, resulting in patented and commercialized medical equipment, such as the Sonolith® andAblatherm® devices by EDAP Technomed and more recently Thyros® by Theraclion and EyeOP1® by EyeTechCare. These developments were the first of their kind in Europe and in the US. LabTAU has a portfolio of more than 20 active patents.
The research on ultrasound therapy conducted in LabTAU is widely regarded as being at the forefront of worldwide developments in this field leading to international activity by means of several actions: reception of foreign researchers, European actions, bilateral collaboration contracts, thesis co-supervision.